Lumeva · MIG · Australia · Primary care physician · captured by Luis Ortega on 03 Feb 2026 · reviewed by Dr. Sophie Laurent on 04 Feb 2026
Verbatim as captured; never edited
Primary care physician at Royal Melbourne Hospital raised drug interactions during a scientific exchange. They noted that colleagues in their network share the view.
Human-approved by Dr. Sophie Laurent on 04 Feb 2026
Drug interactions: recurring question reported by primary care physician (AU).
helixor-private-llm-2026.05 · generated 03 Feb 2026, 10:00 UTC
AI summary
Drug interactions raised by primary care physician; suggest routing to HEOR.
Source spans used by the model
Primary care physician at Royal Melbourne Hospital raised drug interactions during a scientific exchange. They noted that colleagues in their network share the view.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Health economics | Health economics |
| Function | HEOR | HEOR |
| Priority | High | High |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 3 | 20% | 12.0 |
| Strategic alignment | 2 | 20% | 8.0 |
| Scientific importance | 4 | 15% | 12.0 |
| Urgency | 3 | 15% | 9.0 |
| Novelty | 4 | 10% | 8.0 |
| Actionability | 3 | 10% | 6.0 |
| Confidence | 4 | 5% | 4.0 |
| Breadth of occurrence | 4 | 5% | 4.0 |
| Total | High 63 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
01 Feb 2026 · Dr. Noor Sato, Royal Melbourne Hospital · MSL Luis Ortega
Insight
Reviewed 04 Feb 2026 by Dr. Sophie Laurent
Action
Publication project · David Chen · In progress
Decision
Outcome
Closure
Duplicate theme merged into strategic objective review.